ASTRAZENECA FDA Approval NDA 022047

NDA 022047

ASTRAZENECA

FDA Drug Application

Application #022047

Documents

Letter2011-09-28
Letter2008-10-09
Letter2008-05-28
Letter2009-12-30
Letter2008-08-19
Letter2011-07-12
Letter2011-05-19
Letter2010-12-07
Letter2013-05-02
Letter2011-11-14
Letter2013-05-02
Letter2016-06-21
Label2008-11-07
Label2008-11-07
Label2008-08-29
Label2009-12-11
Label2009-12-11
Label2013-05-01
Label2011-07-12
Label2013-05-01
Label2013-10-31
Label2016-05-25
Label2016-06-21
Review2011-09-27
Review2014-08-01
Letter2008-03-17
Letter2008-10-09
Letter2008-10-09
Letter2009-12-30
Letter2008-08-13
Letter2009-12-30
Letter2009-12-30
Letter2009-12-30
Letter2011-07-12
Letter2013-05-02
Letter2013-05-02
Letter2013-10-30
Label2008-03-17
Label2008-11-07
Label2009-12-11
Label2009-12-11
Label2009-12-11
Label2011-07-12
Label2011-05-23
Label2010-12-04
Label2013-05-01
Label2013-05-01
Other Important Information from FDA2011-12-22
Label2017-02-24
Letter2017-03-02
Label2018-11-30
Label2018-11-30
Medication Guide2018-11-30
Medication Guide2018-11-30
Letter2018-12-20
Letter2018-12-20
Letter2019-08-27
Label2019-08-27
Medication Guide2019-08-27
Letter2020-02-06
Label2020-02-07
Letter2020-05-21
Label2020-05-22
Medication Guide2020-05-22
Letter2020-09-21
Letter2020-09-21
Label2020-09-22
Medication Guide2020-09-22
Label2022-01-28
Medication Guide2022-01-28
Letter2022-01-31

Application Sponsors

NDA 022047ASTRAZENECA

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005

Application Products

001TABLET, EXTENDED RELEASE;ORALEQ 50MG BASE1SEROQUEL XRQUETIAPINE FUMARATE
002TABLET, EXTENDED RELEASE;ORALEQ 200MG BASE1SEROQUEL XRQUETIAPINE FUMARATE
003TABLET, EXTENDED RELEASE;ORALEQ 300MG BASE1SEROQUEL XRQUETIAPINE FUMARATE
004TABLET, EXTENDED RELEASE;ORALEQ 400MG BASE1SEROQUEL XRQUETIAPINE FUMARATE
005TABLET, EXTENDED RELEASE;ORALEQ 150MG BASE1SEROQUEL XRQUETIAPINE FUMARATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2007-05-17UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2008-03-13N/A
EFFICACY; EfficacySUPPL6AP2008-10-08UNKNOWN
EFFICACY; EfficacySUPPL7AP2008-10-08UNKNOWN
EFFICACY; EfficacySUPPL8AP2008-10-08UNKNOWN
LABELING; LabelingSUPPL9AP2008-05-21STANDARD
EFFICACY; EfficacySUPPL11AP2009-12-02UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2008-08-11N/A
LABELING; LabelingSUPPL16AP2009-12-02
LABELING; LabelingSUPPL17AP2009-12-02
LABELING; LabelingSUPPL18AP2008-08-14STANDARD
LABELING; LabelingSUPPL19AP2009-12-02
LABELING; LabelingSUPPL22AP2009-12-02
LABELING; LabelingSUPPL23AP2011-07-08UNKNOWN
LABELING; LabelingSUPPL24AP2011-05-17UNKNOWN
LABELING; LabelingSUPPL25AP2010-12-01901 REQUIRED
LABELING; LabelingSUPPL26AP2013-04-30
LABELING; LabelingSUPPL27AP2011-07-08UNKNOWN
REMS; REMSSUPPL28AP2011-11-09N/A
EFFICACY; EfficacySUPPL29AP2013-04-30STANDARD
LABELING; LabelingSUPPL30AP2013-04-30
LABELING; LabelingSUPPL31AP2013-04-30
LABELING; LabelingSUPPL33AP2018-11-29STANDARD
LABELING; LabelingSUPPL34AP2013-10-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2015-01-26
LABELING; LabelingSUPPL37AP2018-11-29STANDARD
LABELING; LabelingSUPPL38AP2016-06-17901 REQUIRED
LABELING; LabelingSUPPL39AP2017-02-23901 REQUIRED
LABELING; LabelingSUPPL40AP2019-08-26STANDARD
LABELING; LabelingSUPPL41AP2020-09-18STANDARD
LABELING; LabelingSUPPL42AP2020-03-27STANDARD
LABELING; LabelingSUPPL43AP2020-02-05901 REQUIRED
LABELING; LabelingSUPPL44AP2020-09-18STANDARD
LABELING; LabelingSUPPL46AP2022-01-27STANDARD

Submissions Property Types

SUPPL6Null6
SUPPL7Null6
SUPPL8Null6
SUPPL11Null6
SUPPL16Null0
SUPPL17Null0
SUPPL19Null0
SUPPL22Null0
SUPPL23Null7
SUPPL24Null6
SUPPL25Null6
SUPPL26Null0
SUPPL27Null6
SUPPL28Null6
SUPPL29Null7
SUPPL30Null0
SUPPL31Null0
SUPPL33Null15
SUPPL34Null15
SUPPL36Null0
SUPPL37Null15
SUPPL38Null6
SUPPL39Null7
SUPPL40Null7
SUPPL41Null15
SUPPL42Null15
SUPPL43Null7
SUPPL44Null15
SUPPL46Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB
005PrescriptionAB

CDER Filings

ASTRAZENECA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22047
            [companyName] => ASTRAZENECA
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/022047s041s044lbl.pdf#page=52"]
            [products] => [{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 50MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 200MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 300MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 400MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 150MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"09\/18\/2020","submission":"SUPPL-44","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022047s041s044lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2020","submission":"SUPPL-42","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022047Orig1s042lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2020","submission":"SUPPL-42","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022047Orig1s042lbl.pdf\"}]","notes":""},{"actionDate":"02\/05\/2020","submission":"SUPPL-43","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022047s043lbl.pdf\"}]","notes":""},{"actionDate":"08\/26\/2019","submission":"SUPPL-40","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/022047s040lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2018","submission":"SUPPL-37","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022047s033s037lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2018","submission":"SUPPL-33","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022047s033s037lbl.pdf\"}]","notes":""},{"actionDate":"02\/23\/2017","submission":"SUPPL-39","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022047s039lbl.pdf\"}]","notes":""},{"actionDate":"02\/23\/2017","submission":"SUPPL-39","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/022047s039lbl.pdf\"}]","notes":""},{"actionDate":"06\/17\/2016","submission":"SUPPL-38","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/022047s038lbl.pdf\"}]","notes":""},{"actionDate":"01\/26\/2015","submission":"SUPPL-36","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022047s036lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"10\/29\/2013","submission":"SUPPL-34","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022047s034lbl.pdf\"}]","notes":""},{"actionDate":"04\/30\/2013","submission":"SUPPL-31","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022047s026s029s030s031lbl.pdf\"}]","notes":""},{"actionDate":"04\/30\/2013","submission":"SUPPL-30","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022047s026s029s030s031lbl.pdf\"}]","notes":""},{"actionDate":"04\/30\/2013","submission":"SUPPL-29","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022047s026s029s030s031lbl.pdf\"}]","notes":""},{"actionDate":"04\/30\/2013","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022047s026s029s030s031lbl.pdf\"}]","notes":""},{"actionDate":"07\/08\/2011","submission":"SUPPL-27","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022047s023s027lbl.pdf\"}]","notes":""},{"actionDate":"07\/08\/2011","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022047s023s027lbl.pdf\"}]","notes":""},{"actionDate":"05\/17\/2011","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022047s024lbl.pdf\"}]","notes":""},{"actionDate":"12\/01\/2010","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022047s025lbl.pdf\"}]","notes":""},{"actionDate":"12\/02\/2009","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022047s011s016s017s019s022lbl.pdf\"}]","notes":""},{"actionDate":"12\/02\/2009","submission":"SUPPL-19","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022047s011s016s017s019s022lbl.pdf\"}]","notes":""},{"actionDate":"12\/02\/2009","submission":"SUPPL-17","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022047s011s016s017s019s022lbl.pdf\"}]","notes":""},{"actionDate":"12\/02\/2009","submission":"SUPPL-16","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022047s011s016s017s019s022lbl.pdf\"}]","notes":""},{"actionDate":"12\/02\/2009","submission":"SUPPL-11","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022047s011s016s017s019s022lbl.pdf\"}]","notes":""},{"actionDate":"10\/08\/2008","submission":"SUPPL-8","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s006s007s008lbl.pdf\"}]","notes":""},{"actionDate":"10\/08\/2008","submission":"SUPPL-7","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s006s007s008lbl.pdf\"}]","notes":""},{"actionDate":"10\/08\/2008","submission":"SUPPL-6","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s006s007s008lbl.pdf\"}]","notes":""},{"actionDate":"08\/11\/2008","submission":"SUPPL-13","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s013lbl.pdf\"}]","notes":""},{"actionDate":"08\/11\/2008","submission":"SUPPL-13","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s013lbl.pdf\"}]","notes":""},{"actionDate":"03\/13\/2008","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022047s002lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"EQ 50MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"EQ 200MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"EQ 300MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"EQ 400MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"EQ 150MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-09-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.